← Back to stories
AI Labs

OpenAI acquires Orchestra Bio

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

You're reading a preview. The full article is published by OpenAI on their website.

Read the full story on OpenAI